Flagship explainer
What drives Maravai LifeSciences Holdings, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$131M | FY2025 |
| |
| Income before tax | −$235M | FY2025 |
|
| Operating income | −$215M | FY2025 |
|
| $186M | FY2025 |
| |
| Ending assets | $771M | FY2025 |
|
| Beginning assets | $1.0B | FY2024 |
|
| $212M | FY2025 |
| |
| $325M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001823239-26-000011